Heme oxygenase-1 (HO-1), the ratelimiting enzyme in heme degradation, is an integral membrane protein of the smooth endoplasmic reticulum. However, we detected HO-1 immunoreactive signal in the nucleus of cultured cells after exposure to hypoxia and heme or heme/hemopexin. Under these conditions, a faster migrating HO-1 immunoreactive band was enriched in nuclear extracts suggesting that HO-1 was cleaved to allow nuclear entry. This was confirmed by the absence of immunoreactive signal with an antibody against the C-terminus and the lack of a C-terminal sequence by GC-MS. Incubation with Leptomycin B (LMB) prior to hypoxia abolished nuclear HO-1 and the faster migrating band on Western analysis, suggesting that this process was facilitated by CRM1. Furthermore, preincubation with a cysteine protease inhibitor prevented nuclear entry of GFPlabeled HO-1 demonstrating that protease mediated C-terminal cleavage was also necessary for nuclear transport of HO-1. Nuclear localization was also associated with reduction of HO activity. HO-1 protein, whether it was enzymatically active or not, mediated activation of oxidant responsive transcription factors including AP-1. Nevertheless, nuclear HO-1 equally protected cells against hydrogen peroxide mediated injury as cytoplasmic HO-1. We speculate that nuclear localization of HO-1 protein may serve to up-regulate genes that promote cytoprotection against oxidative stress.
INTRODUCTION
Heme oxygenase catalyzes the degradation of heme and the formation of biliverdin and carbon monoxide. It is highly inducible in response to various stimuli including oxidative stress, heavy metals, UV radiation and inflammation (1) (2) (3) (4) . Cytoprotective roles for HO have been demonstrated in many models however; the mechanisms by which this occurs are still under intensive study. Many have speculated that heme catabolites such as biliverdin, or its derivative bilirubin, and carbon monoxide or that the degradation of the pro-oxidant heme results in cytoprotection against oxidative stress (5) (6) (7) .
Nevertheless, all of the byproducts of the HO reaction, despite being potentially cytoprotective are also cytotoxic. Bilirubin is a potent neurotoxin (8) as is carbon monoxide (9) . Furthermore, the HO reaction releases iron, which could interact with cellular oxidants to generate the hydroxyl radical (10) . Transfection with an inactive HO-1 mutant protein results in cytoprotection against chemically-induced oxidative stress (11) . Because this effect of the mutant HO-1 could not be attributable to changes in heme catabolites, it alludes to a role for the HO-1 protein itself. Furthermore, the inactive form of HO-1 increased catalase and glutathione content (11) . This suggests that the HO-1 protein itself may play a role in cellular signaling. If this were true, HO-1 would need to migrate to the nucleus or produce nuclear changes that affect transcription. There are several examples of cytoplasmic enzymes serving in nuclear functions.
The steroid regulatory element binding protein (SREBP) is usually bound to the smooth endoplasmic reticulum (sER) at its C-terminus and locates to the nucleus after proteolytic cleavage (12) . The amphitrophic protein, CTP: phosphocholine cydidylyltransferase is activated when bound to the sER but is enzymatically inactive in a nuclear reservoir (13) . The transcription factor ATF6 is a type II transmembrane (TM) glycoprotein that is usually anchored to the sER but it can be proteolytically cleaved at its N-terminus and migrate to the nucleus in response to ER stress (14) .
HO-1 was first identified as an integral type I membrane protein of the sER, oriented such that most of the protein, including the active site, resides in the cytoplasm. A short C-terminus resides within the lumen of the sER (15) . Translocation of HO-1 to the nucleus would require one or more proteolytic cleavages: either on the cytosolic side of the TM region and/or also within the TM domain to release a large HO-1 fragment, containing the N-terminus, into the cytosol. In vitro experiments document tryptic cleavage of the C-terminus of purified HO-1 protein (16) . Whether this occurs in intact cells is still unknown. Most proteins that migrate to the nucleus have nuclear localization sequences (NLS) that are essential for nuclear uptake (reviewed in (17) ). Nonetheless, small proteins (less than 50 kDa) that lack an NLS do migrate to the nucleus (18) . So far, no NLS has been identified on HO-1. In addition to NLS sequences, nuclear export sequences (NES) are also important for the proper localization of some cytoplasmic proteins (19). These are leucine-rich regions, which bind with the export receptor CRM1 forming a complex with Ran-GTP. This allows for passage through the nuclear pore (20) . Leptomycin-B (LMB) can inhibit the CRM1/NES binding complex (19, 20) . This block in nuclear export results in a predominant nuclear expression of a protein. No one has evaluated whether HO-1 has a functional NES; however, there is a highly conserved region on the rat HO-1 protein at amino acids 207-221 (LNIELSEELQALL) with greater than 90% homology to the NES motif [LX (1) (2) (3) LX (2) (3) LXL on the human immunodeficiency virus type 1 Rev protein (HIV-Rev) which binds to unspliced HIV-1 premRNA and exports it from the nucleus. (21) . Once HO-1 accesses the nucleus, it is important to understand how it affects cellular functions.
One likely signaling mechanism is modulation of gene transcription. Kravets et al reported that biliverdin reductase, which catalyzes reduction of the HO activity product, biliverdin, to bilirubin, can induce the expression of HO-1 protein, suggesting that various components of the bilirubin system could regulate the expression of genes in the pathway (22) . This occurred through activation of transcription factors found within the genomic sequence upstream of the HO-1 gene. Distal enhancer (DE) 1 and DE2 located at -4kb and -10 kb upstream of the transcription start site respectively are critical for HO-1 induction by most oxidative stimuli, including heme, heavy metals, and hydrogen peroxide (2, (23) (24) (25) . Both DE1 and DE2 regions contains multiple stressresponsive elements (StRE) that represent binding sites of regulatory proteins such as AP-1, Jun, CREB, Maf and the Cap'n'collar/basic-leucine zipper (CNC-bZIP) transcription factors (26, 27) . Unlike biliverdin reductase, HO-1 is not a transcription factor therefore it is more likely to have an indirect effect on gene transcription, perhaps through modulation of transcription factor binding.
Here, we demonstrate that, in response to three different stimuli: hypoxia (3% oxygen), incubation with hemin or H/HPX, HO-1 can migrate to the nucleus. Nuclear translocation is associated with truncation of the C-terminus of HO-1. In addition, a motif, which we term a putative "nuclear shuttling sequence (NSS)", is important for nuclear import of HO-1. Furthermore, C-terminal truncation of the protein and nuclear migration is also modified by proteolytic cleavage. Nuclear migration resulted in loss of HO activity.
We further show that inntracytoplasmic delivery of HO-1 protein activated several transcription factors involved in oxidative stress and that delivery of HO-1 protein or transfection of HO-1 cDNA resulted in activation of a 15 kB oxidant responsive HO-1 promoter attached to luciferase and protected against hydrogen peroxide mediate injury, whether the HO-1 protein was active or not. 
MATERIALS AND METHODS

Cells lines
Models to modify HO-1 expression
Hypoxic exposure 3T3 and the 293 FLAGHO-1 cells were exposed to hypoxia (3 % O 2 ) for 0-48 hours.
Incubation with hemin in vitro
3T3 cells were incubated with hemin 30 µM for 0-48 hours.
Incubation with H/HPX in vitro
Intact rabbit hemopexin was purified and stoichiometric 1:1 H/HPX complexes (>90-95% saturation) characterized and quantitated using heme dissolved in DMSO, as previously described (28, 29 
Identification of region of the HO-1 protein necessary for nuclear translocation
To determine which regions of the protein are responsible for nuclear localization, various rat HO-1 cDNA constructs were inserted into a pEGFP-c1 vector (Clontech, Palo Alto, CA). A mutant expressing an HO-1 protein lacking the Cterminal amino acids 267-289 fused to EGFP protein (EGFPHO-1CΔ23) was generated with appropriate primers (see Table 1 ). The PCR product was cloned into the BglII/BamHI site of the pEGFP-C1 vector.
A mutant expressing HO-1 protein lacking amino acids 207-221 with >90% homology to a known NES (termed NSS; EGFPHO-1ΔNSS) was also generated in a two step process with PCR primer pairs (see Table 1 ). The first PCR product was cloned into the BglII/KpnI site and the second PCR fragment was cloned into the KpnI/BamHI site of the pEGFP-c1 vector.
A double deletion mutant lacking the Cterminus and the NSS (EGFPHO-1CΔ23ΔNSS) was generated as above with substitution of the last PCR primer as shown in Table 1 . Full-length rat HO-1 cDNA (1-867 bp) was amplified by PCR (see Table 1 ). The PCR product was cloned into the BamHI/XhoI site of pcDNA3.1/His (Invitrogen) to generate HisHO1myc construct. The HisHO1myc fragment was then subcloned into p3XFLAGCMV (Sigma) to generate HisHO1FLAG. A rat HO-1 cDNA (HisHO1mutFLAG) expressing an enzymatically inactive HO-1 with a substitution of Histidine 25 to Alanine was derived from the HisHO1FLAG by PCR using site-directed mutagenesis kit from Stratagene (QuickChange II, catalog # 200523-4).
These constructs were verified by DNA sequencing and then transfected into 3T3 cells using lipofectamine 2000 (Invitrogen). The transfected cells were grown on slides and visualized by conventional fluorescence microscopy or laser confocal microscopy as previously described (33) . Fluorescence in the 484 nm excitation and 510 nm emission ranges were used to detect EGFP.
Evaluation of the putative HO-1 NSS in nuclear localization
To test whether the NSS alone mediates compartmentalization of protein into the nucleus, an oligonucleotide containing the NSS sequence corresponding amino acids 206-222 of rat HO-1 was generated (see Table 1 ). This sequence was fused to the C-terminus of the EGFP protein (NSSEGFP) and the sequence was confirmed by DNA sequencing.
The NSSEGFP or EGFP were transiently transfected into the 3T3 cells. The localization of the EGFP protein was determined using immunocytostaining with the GFP antibody (Molecular Probes, Inc. Eugene, OR). Co-staining with a cytoplasmic protein marker calnexin and nuclear marker DAPI were performed to demonstrate the sub-cellular localization using fluorescence microscopy.
Evaluation of the role of proteases on HO-1 subcellular localization
Cultured 3T3 cells were exposed to hypoxia as described above. The media were changed to DMEM containing 0.5% FBS. Cells were then incubated with 50 µM of the cysteine protease inhibitor E64d (#E 3132, Sigma, St. Louis, MI) 20 min prior to exposure to hypoxia. Cells were visualized by fluorescent microscopy after immunohistochemical staining with HO-1 antibodies. Cell lysates and nuclear extracts were also subjected to Western analysis.
Detection of nuclear HO-1 protein
An antibody specific for the C-terminal amino acids of the HO-1 protein (M19) was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). An N-terminal antibody to a 30 residue synthetic peptide based on the human HO-1 (SPA-896) was obtained from Stressgen (Assay Designs, MI).
In order to characterize the nuclear HO-1, 293 FLAGHO-1 transfected cells were exposed to hypoxia. The nuclear FLAGHO-1 was isolated and enriched using a FLAG affinity column as per the manufacter's instruction (Anti-FLAG M2, #A 2220; Sigma). 
Identification of nuclear
Determination of HO enzymatic activity
Heme oxygenase activity was measured by detecting the amount of carbon monoxide generated from cell lysates, as previously described (34)
Intracytoplasmic delivery of HO-1 Protein
A GST HO-1 fusion construct was expressed in the E.coli strain BL21 (Invitrogen.). Bacteria were grown to an OD of 0.6-0.8. Thereafter, the fusion protein was induced with 100 IPTG at 30°C. After 5 hrs, bacteria were harvested and sonicated for 5 minutes. The fusion protein was purified using a GST-purification module (Amersham Biosciences, Piscataway, NJ) according to the manufacturer's instruction.
Ten µg of GST HO-1 protein was delivered in the 3T3-HO-1/luc or MEF cells using the Pro-Ject™ System (Pierce, Rockford, IL, USA) as per the manufacturer. Briefly, the ProJect™ reagent was solubilized in 250 l methanol. The methanol was evaporated overnight under a sterile hood and the dried Pro-Ject was stored at -20 o C until use. Purified HO-1 protein was diluted in PBS and added to the dried Pro-Ject reagent. After 5 minutes incubation, the mixture was added to the cell culture medium with 5% serum. After 3 h, cells were washed with PBS, and maintained in serum-free medium for the first 4 h of the incubation.
Thereafter, 5% FBS was reincorporated. In other experiments, purified mutant HO-1 protein (His25Ala) devoid of catalytic activity (gift of Paul Ortiz de Montellano, UCSF, San Francisco, CA), was delivered to the cells as described above.
Transient transfection with HO-1 cDNA
Transient transfection was performed in NIH3T3 cells using Lipofectamine 2000 (Invitrogen). Briefly, one day before transfection, 10 5 cells were seeded in 24-well plates with antibiotics free growth medium. DNA (0.8 µg) and 2 µl of lipofectamine 2000 reagent were diluted into 50 µl of DMEM separately. After 5 minutes incubation, the DNA and lipofectamine solution were mixed and incubated for additional 20 minutes at room temperature. The DNA/Lipofectamine complex was then added to the cells. Cells were grown for 48 hours before being subjected to assays.
Evaluation of transcription factor activation
To determine whether HO-1 modulates cellular signaling, lysates from cells receiving GST-purified wild type and mutant HO-1 protein were evaluated for changes in transcription factor activation compared to controls. This was done using a commercially available kit (TransSignal ™ Protein/DNA array I, Panomics, Redwood City, CA, USA) according to the manufacturer's instructions. This array did not include Nrf2 or Bach-1.
Verification of DNA binding to transcription factors
Activations observed with the transcription factor array were verified by electrophoresis mobility shift assay (EMSA) using the appropriate transcription factor consensus DNA binding sequence.
After protein delivery, cells were harvested and the nuclear extract was obtained using a commercially available kit (Pierce, Rockford, IL) after addition of a protease inhibitor cocktail solution (Sigma). The 32 P-labeled probes were incubated with 20 µg of the nuclear protein in a buffer containing 10 mM HEPES (pH 7.9), 1 mM EDTA, 80 mM KCl, 1 µg poly [dIdC], and 4% Ficoll. The reaction mixture was incubated at room temperature for 30 min and electrophoresed on 6% polyacrylamide gels. To distinguish nonspecific binding of the nuclear proteins, competition reactions were performed by adding either 10-or 100-fold excess of non-radiolabeled probe or of a mutated probe to exclude nonspecific binding.
Oligonucleotides with the consensus DNA binding sequences for the given transcription factors were synthesized by the PAN Facility at Stanford University (see Table 2 ).
Visualization of oxidant responsive promoter activation
After transfection or protein delivery, the 3T3-HO-1/luc cells were incubated with DMEM containing 1% luciferin for 5 min. The cultures were imaged using the IVIS camera system. (Xenogen, Alameda, CA). Pseudoimages of the photon emission were generated and light intensity was expressed as a ratio to cell counts, as previously described (32) .
Statistical analysis
For comparison between treatment groups, the Null hypothesis that there is no difference between treatment means was tested by a single factor analysis of variance (ANOVA) for multiple groups or unpaired t-test for two groups (Statview 4.02, SAS, Berkeley, CA). Statistical significance (p < 0.05 or p<0.001) between and within groups was determined by means of the Fischer method of multiple comparisons.
RESULTS
HO-1 protein localizes to the nucleus after hypoxic exposure.
In cultured 3T3 cells, nuclear localization of HO-1 protein was observed after hypoxic exposure ( Figure 1A ). The HO-1 signal was enriched in the nucleus as with other known nuclear proteins such as acetylated histone 3 and CRM1 (data not shown).
In the sER, HO-1 is oriented such that most of the protein, including the active site, resides in the cytoplasm. A short C-terminus resides within the lumen of the sER (35) . With hypoxic exposure, two HO-1 immunoreactive bands were observed on Western analysis in the whole cell extract, with one band migrating at ~28 kDa and the other migrating at 32 kDa ( Figure  1B ). Using the M19 antibody directed towards the C-terminus of HO-1, loss of all HO-1 immunoreactivity was noted in the nuclear extracts whereas one immunoreactive band migrating at 32 kDa was observed in the whole cell extracts ( Figure 1B ). These data suggest that the nuclear HO-1 immunoreactive form does not contain the C-terminus. Lack of nuclear localization of the M19 immunoreactive signal by fluorescence microscopy provides further evidence that the nuclear form of HO-1 is devoid of the C-terminus ( Figure 1C ).
HO-1 protein localizes to the nucleus after hemin or H/HPX incubation.
To address whether the generation of a nuclear form of HO-1 was a general phenomenon, we also investigated whether other known inducers of HO-1 had a similar effect on HO-1 nuclear migration as hypoxia. In cultured Hepa cells, increased signal intensity and nuclear localization of HO-1 immunoreactive protein was observed after incubation with 10 µM heme for 4 hours or 20 µM H/HPX for 5 hours (Figure 2A ). Using confocal microscopy and co-staining with propidium iodide (PI), the M19 immunoreactive signal was never localized to the nucleus but rather remained in the perinuclear area ( Figure 2B ). Additionally, nuclear extracts were enriched with a faster migrating band (~28 kDa) and were devoid of the native 32 kDa HO-1 immunoreactive band on Western analysis, corroborating that the nuclear form of HO-1 is truncated at the Cterminus ( Figure 2C ).
The C-terminal region of HO-1 inhibits nuclear import.
To further analyze the role of the Cterminus of HO-1 protein using immunocytostaining, we evaluated nuclear localization of EGFP protein fused to HO-1 fragments lacking the C-terminal 23 amino acids. Transfection with the full length EGFPHO-1 cDNA resulted in cytoplasmic fluorescence whereas nuclear fluorescent signal was associated with transfection of the C-terminal mutant lacking the last 23 amino acids (CΔ23) ( Figure 3A ).
There is a highly conserved leucine rich region with strong homology for the HIV-Rev NLS (21) near the C-terminus of HO-1 protein, referred to as NSS (see crystal structure on Figure  3 ). Transfection of a mutant with double deletion lacking the NSS and CΔ23 (CΔ23ΔNSS) yielded cytoplasmic fluorescence ( Figure 3A. ) indicating that the NSS functions to facilitate nuclear import. Paradoxically, when the NSS fused to GFP it behaved more as a putative NES ( Figure 3B) ) suggesting that other elements of the HO-1 protein are also required to mediate the NSS function.
Typically, NES-like leucine rich regions bind to CRM1. We also demonstrated interaction of HO-1 protein to CRM1 by recovering 35 Slabeled in an in vitro translated HO-1 protein after co-incubation with GST-CRM1 using a pull down assay ( Figure 4A ). However, deletion of the putative NSS did not completely eliminate HO-1 binding to CRM1, indicating that there are likely other CRM1 binding regions on the protein. CRM1 mediated nuclear export can be effectively blocked by LMB. We therefore tested whether pre-incubation of cultured cells with LMB and exposure to hypoxia could result in the exclusion of the HO-1 immunoreactive signal from the nucleus. This was in fact observed ( Figure 4B ) as well as loss of the more rapidly migrating (28 kDa) immunoreactive HO-1 band on Western analysis after both hypoxia and hemin incubation ( Figure 4C ).
The nuclear form of HO-1 lacks 52 amino acids from the C-terminus.
To verify loss of the C-terminus and to determine the actual cleavage site of the HO-1 the nuclear fraction of the 293 FLAGHO-1 cells was isolated using a stringent method. The nuclear fraction showed no cytoplasmic contamination as verified by exclusion of calnexin (data not shown). After purification with a FLAG column the eluted contents showed a predominant band (arrow) between 30 and 45 kDa on a colloidal blue stained SDS-PAGE gel ( Figure 5 ). This was further verified to be immunoreactive with both FLAG and HO-1 antibodies (data not shown). MALDI-TOF mass spectroscopy showed a peak with a molecular mass of 34,071.64 Da. Trypsin digested peptide sequences from this band revealed an intact N-terminus and lack of C-terminus of the HO-1 using LC/MS/MS. After deduction of the FLAG molecular weight the truncated HO-1 mass was 27,185 Da corresponding to the amino acids 1 to 237 of rat HO-1 protein.
Protease inhibition reduces nuclear localization of HO-1.
Calpains are ubiquitous calciumdependent cysteine proteases that regulate several proteins involved in cell cycle progression, including p27Kip1 (19) as well as c-fos and c-jun (36) . Calpain mediated cleavage of proteins such as amyloid precursor protein found in Alzheimer disease, results in the formation of fragments that are targeted to the nucleus and regulate gene expression (37) .
To understand whether truncation of HO-1 at the C-terminus could be due to proteolytic cleavage by proteases such as calpains, 3T3 cells were preincubated with a cysteine protease inhibitor (E64d) prior to hypoxic exposure. The E64d compound is esterified and diffuses readily into the cytoplasm to inhibit calpain activity (38) . This obviated nuclear translocation of HO-1immunoreactive signal ( Figure 6A ).
In addition, preincubation with E64d visibly reduced the intensity of the faster migrating band on Western analysis, further documenting that this band was the result of proteolytic cleavage of the HO-1 protein ( Figure  6B ). In contrast to these observations, nuclear translocation of HO-1 after hemin could not be obviated by incubation with catalase (0.3 µM) or superoxide dismutase (0.6 µM) (data not shown), suggesting that the cleavage was not a result of direct oxidative damage to the HO-1 protein.
Nuclear translocation of HO-1 reduces HO activity.
To understand the effect of nuclear localization on HO-1 activity, cell lysates from 3T3 cells exposed to hypoxia were evaluated for CO formation in the presence of excess heme. Total HO activity was reduced after hypoxia as compared to cell lysates from controls in normal cell culture conditions, despite the increased HO-1 protein observed on Western analysis ( Figure 7A ). Because a substantial portion of the HO-1 protein is localized to the nucleus after hypoxia, this implies that the nuclear HO-1 is less active than the form found in the sER. Preincubation with LMB prior to hypoxic exposure restored HO activity to near-basal levels ( Figure 7A ). Since hypoxia and LMB do not substantially increase HO-1 protein content ( Figure 4C ), the lack of HO activity in hypoxia and the reversal effect by LMB is likely due to a shift in unclear localization.
To further understand whether C-terminal truncation results in altered HO activity, transient transfection with FL or with CΔ23 was performed and evaluated for HO activity.
Whereas transfection with FL resulted in a six-fold increase in the HO activity, transfection with CΔ23 resulted in only a 1.2 fold increase as compared to untransfected, lipofectamine treated or vector transfected controls (p = 0.35; Figure 7B ). Western analysis documented that there was no loss of HO-1 immunoreactive protein after the CΔ23 transfection (data not shown).
Overall, these data demonstrate that nuclear translocation of HO-1 is associated with loss of HO activity despite abundance of HO-1 protein.
HO-1 protein delivery mediates activation of various transcription factors.
Nuclear localization of HO-1 protein suggests a signaling role. Because HO-1 is not a traditional transcription factor, we hypothesized that HO-1 protein could modulate oxidantresponsive transcription factor binding thus modulating gene expression.
A lipid-based protein delivery system (Project TM ; Pierce) was used to deliver HO-1 protein intracytoplasmically. A GST-HO-1 fusion protein was expressed and purified with a GST column followed by thrombin digestion to cleave the GST tag. To determine the efficiency of the protein delivery system and to optimize transfection conditions, we first delivered exogenous HO-1 protein into HO-1 deficient MEF cells. Immunoreactive signal of HO-1 was detected within 2 hours after transfection in both the whole cell and nuclear extracts, demonstrating the effectiveness of the protein delivery system ( Figure 8A ). In this model, the HO-1 protein levels peaked at 2 h and returned to baseline by 8 h, suggesting rapid degradation of the HO-1 protein.
To determine which transcription factors are regulated by HO-1 protein, a trans-signal array technique was employed to assess differential DNA binding activities of 54 transcription factors after intracytoplasmic delivery of HO-1 protein. Activation was only considered positive if there was a >3 fold increase compared to controls treated with Pro-Ject TM alone (Table 3) . To further determine whether transcription factor activation was due to the byproducts of the HO reaction or the HO-1 protein itself, the assay was also conducted in cells where the inactive HO-1 mutant His25Ala protein was delivered. After HO-1 or His25Ala HO-1 protein delivery, transcription factors activator protein (AP)-1, AP-2 and Brn-3 showed 6 fold, 6 fold and 9 fold increased activation respectively whereas core binding factor (CBF) was activated 3 fold by the active HO-1 but was activated 9 fold by the mutant protein, suggesting an inhibitory effect of the HO byproducts on the activation of this transcription factor. In the case of CDP, Ets/ PEA3, STAT 1, STAT 3 and STAT 4, these were activated only with delivery of the native enzyme but not with the mutant protein.
In contrast to the above, DNA binding activity of transcription factor NF-kB was downregulated to 65% after delivery of the mutant HO-1 protein but was unchanged after delivery of the native HO-1. Activity of transcription factor SP-1 was down regulated by delivery of both wild type and mutant HO-1 proteins.
Transcriptional factor activation was further verified using EMSA to demonstrate binding of nuclear proteins to the consensus DNA sequence. Increased binding of nuclear proteins to the AP-1 consensus sequence after delivery of native or mutant HO-1 protein was observed. To further substantiate AP-1 activation, a 5-fold increase in nuclear phosphorylated c-jun was observed after HO-1 protein delivery (Figure 9 , inset). Binding to Brn-3, CDP and CBF and Stat-3 binding sites was also enhanced ( Figure 9A ). Neither Stat-1 nor Ets/PEA3 showed altered DNA binding by EMSA, suggesting non-specific activation on the transcription factor array (data not shown). Binding of nuclear proteins to NF-KB and SP-1 sites was visibly diminished after delivery of either the native or the inactive HO-1 protein in contrast to the transcription factor array data ( Figure 9B ). Because Nrf2 is an important mediator of oxidative stress signaling, binding to this consensus sequence was also investigated. No differences in Nrf2 binding were observed after delivery of native or mutant HO-1 protein (data not shown).
HO-1 over-expression activates an oxidant responsive HO-1 promoter.
To determine the role of HO-1 protein in the regulation of an oxidative stress responsive promoter, the lipid-based protein delivery system (Project TM , Pierce), was used to incorporate HO-1 protein intracytoplasmically into NIH3T3 cells stably transfected with a luciferase reporter driven by a 15kb HO-1 promoter (3T3-HO-1/luc). This reporter contains multiple oxidant responsive transcription factors as previously described (39) . Luciferase activity in these cells directly correlates with the promoter activation and can be measured by the photon emission with In Vivo Imaging System (IVIS). Next, we delivered the pure HO-1 Figure 10A ). Cells transfected with HisHO-1FLAG and HisHO-1mutFLAG had similar levels of HO-1 and His signals, suggesting similar transfection and expression efficiency ( Figure 10A ). The 32 kD band detected using an anti-HO-1 antibody represents the endogenous HO-1 protein, whereas the 40 kD band in the same blot represents the transfected HisHO-1FLAG fusion proteins. Anti-His antibody could only detect the 40kD HisHO-1FLAG fusion proteins ( Figure 10A ). Twenty-four hours after transient transfection into the HO-1/luc cells, luciferin was added into the culture medium and luciferase activity was measured with IVIS. As shown in Figure 10B , transfection with HO-1 cDNA was associated with a 3-5 fold increase in HO-1 promoter activation compared with cells transfected with transfection reagent or p3XFLAG vector, as demonstrated by increased photon emission ( Figure 10B ). We also observed that the HO-1Λ23 C-terminally truncated HO-1 increases the promoter activity to 1.8 fold compared to vector control, however, the activity is only 52% compared to the full length HO-1, which activated the promoter to 3.58 fold compared to vector control. Deletions from either the N-or the C-terminus (data not shown) indicate that the intact HO-1 protein is required for full HO-1 promoter activation, however, the Cterminal truncated isoform can also facilitate the promoter activation.
The HO-1 promoter has several antioxidant response elements within the distal enhancer regions. have been identified within each of these enhancer regions. Preliminary evaluations revealed synergistic activation of both the DE1 and DE2 enhancer regions by HO-1 transfection (data not shown). This demonstrates that HO-1 protein modulates oxidant responsive signaling.
Nuclear translocation of HO-1 enhances resistance to H 2 O 2 toxicity but does not protect against hemin-mediated cell death.
In other models, nuclear translocation of a cytoplasmic protein alters its function (13) . In our case, the nuclear form of HO-1 was inactive and resulted in alterations in transcription factors involved in oxidative stress. This suggested that nuclear HO-1 may enhance the protection against oxidative stress. To verify this, cells transfected with EGFPHO-1FL and EGFPHO-1CΔ23 were incubated with 200 µM H 2 O 2 for 4 hours. Transfection with both the FL and the CΔ23 constructs was associated with improved cell viability as compared to vector-transfected controls ( Figure 11A ). None of the other HO-1 fragments i.e. 201, 202-, 456 and 465-, regardless of their nuclear localization pattern, resulted in a significant cytoprotection against H 2 O 2 toxicity (data not shown).
In contrast, only cells transfected with the FL construct that is enzymatically active were protected against hemin (100 µM) toxicity, presumably by allowing for the degradation of the toxic prooxidant and the production of the protective heme catabolites ( Figure 11B ).
DISCUSSION
In the initial purification of HO-1, a 32 kDa microsomal protein was found in the ER (35) . However, HO-1 has been documented in various sub-cellular fractions using immunohistochemical techniques (40, 41) . Here, we document nuclear localization of HO-1 using three separate conditions known to induce HO-1 and demonstrate that the truncated HO-1 protein in the nucleus has reduced enzymatic activity.
After hypoxia or incubation with hemin and H/HPX, HO-1 is clearly observed in the nucleus and co-localizes with known nuclear proteins. Because HO-1 is an integral membrane protein of the sER, nuclear translocation would require cleavage of the membrane-bound domain.
In an earlier publication, a 28 kDa protein lacking the C-terminal 23 amino acids of HO-1 was recovered after trypsin incubation (16) . This HO-1 was no longer membrane-bound but watersoluble. In part agreement with this finding, our mass spectroscopy results identified a nuclear form of HO-1 that was 27 kDa in size and was lacking the C-terminus. This could allow for translocation to the nucleus. Although nuclear import of small proteins less than 50 kDa can occur by diffusion (18), nuclear localization is facilitated by the presence of an NLS (17) . No sequence matching an NLS was detected in the HO-1 protein.
Nuclear-cytoplasmic shuttling of various proteins is facilitated by the presence of other sequences. On the rat HO-1, amino acids 207-221 have greater than 90% homology to a published NES (19,42) (referred to as NSS). In other examples, the NES sequence facilitates nuclear export. In fact when the putative NSS sequence was fused to a GFP, it localized to the cytoplasm ( Figure 3B) . Surprisingly, modification of the NSS sequence on HO-1 was required for nuclear import of HO-1 protein because its absence impeded nuclear localization despite truncation of the Cterminus ( Figure 3A ). Although this is the opposite of what we had expected, others show that in some cases NES motifs can function as NLS within a protein as with UL84 of the human cytomegalovirus (43) .
Additionally oxidative modification can modify the function of an NES. In the case of Nrf2, when this protein containing an NLS forms a complex with Keap1, a protein with a dominant NES, it is retained in the cytoplasm. After oxidative modification of the NES, Nrf2 dissociates from Keap1 and migrates to the nucleus (44). Perhaps HO-1 forms a complex with an NLS-containing protein to facilitate its nuclear translocation. Although it is known that HO-1 can interact with other proteins (45) , it remains to be determined whether such an interaction could enhance nuclear shuttling.
Nuclear migration of HO-1 was limited by LMB, an antimicrobial that abolishes CRM1-mediated nuclear-cytoplasmic transport. In most instances, CRM1 serves as an exportin which binds with RanGTP to allow for passage through the nuclear pore and export to the cytoplasm (19). Here we clearly document binding of HO-1 to CRM1 therefore, we suspect that in this case, CRM1 mediated binding to HO-1 facilitates nuclear import rather than export. In one report, nuclear migration of the β-subunit of the nuclear pore targeting complex did not require RanGTP and only required the nuclear pore complexbinding domain which is also involved in NLSmediated import (46). This suggests that CRM1 could be involved in bidirectional shuttling across the nuclear pore.
Hypoxia and/or hemin-enhanced HO-1 nuclear entry could be secondary to toxic effects leading to enhanced nuclear permeability or due to oxidative modification of the nuclear shuttling sequence (44). Although preliminary evidence suggests that the HO-1 protein can be oxidatively modified (Yang et al unpublished observations) and that oxidative modification is known to modify NES-CRM1 binding (44), we have not yet elucidated a specific site of oxidation of the HO-1 protein. Furthermore, the effects of hemin on HO1nuclear localization are not strictly due to oxidative degradation because they cannot be prevented by antioxidants such as catalase and superoxide dismutase.
Previous reports document cleavage of purified HO-1 protein with trypsin in vitro (16) . Here we show that inhibition of a cysteine protease obviates the nuclear translocation of HO-1 and that the precise site of cleavage of HO-1 observed after hypoxia involves the C-terminal 52 amino acids. This suggests that hypoxia-mediated cellular stress activates proteolytic cleavage of the HO-1 protein. Nonetheless, PESTfind analysis detected a C-terminal PEST domain on the mouse HO-1 protein at amino acids 239-254 (RPASLVQDTTSAETPR), as was previously suggested (47) , where the PEST score can be significantly lowered from +3.8 to -20.8 with alanine substitution of the serines and threonines, akin to the PEST domain of IkBα (48) . Importantly, calpain mediated cleavage at this domain would also yield a 27 kDa protein as was detected in our experiments.
When HO-1 localizes to the nucleus after hypoxia, there is an associated loss of total HO activity (the sum of HO-1 and HO-2 derived activities). Because cellular HO-2 protein content is low in the cell lines tested and HO-2 is not induced or inhibited by hypoxia or hemin, this implies that HO-1 becomes less enzymatically active when it is C-terminally truncated and imported to the nucleus. In previous experiments, a 28 kDa HO-1 protein fragment in the presence of detergent solubilized NADPH cytochrome cP450 reductase failed to transfer the second electron from NADPH needed for degradation of the heme (16, 35) .
However, more recent experiments document that truncation from the C-terminus of human HO-1 by 23 amino acids did not reduce HO specific activity, but further truncation by 56 to 68 amino acids did reduce HO activity by 50% (29) . In our experiments, transfection with a construct expressing an HO-1 mutant predominantly expressed in the nucleus with truncation of the 23 terminal amino acids reduced HO activity five-fold. This form of HO-1 was predominantly expressed in the nucleus. Furthermore, the exact site of cleavage of nuclear HO-1 was identified using GC/MS and MALDI-TOF. This demonstrated loss of the terminal 53 amino acids of the HO-1 protein yielding a 27 kD fragment.
This degree of truncation would predictably reduce HO-1 activity.
It is possible that the loss of HO activity could result from additional post-translational modification of the HO-1 protein although this has not been defined yet.
Nonetheless, using modeling, it is clear that C-terminal truncation does not alter the heme catalytic pocket and therefore should not prevent substrate binding and limit HO activity (see Figure 3A) .
To explain the role of nuclear HO-1, we also document the activation of key transcription factors involved in oxidative stress and cellular proliferation after HO-1 delivery. Transcription factor regulation by HO-1 could be mediated by direct protein-DNA interaction akin to the action of other transcription factors. However, structure of HO-1 does not reveal traditional DNA binding motifs, a characteristic of most transcription factors. Direct HO-1 mediated transcriptional activation is less likely without a DNA binding motif as seen with transcription factors (reviewed by (49) . Another potential mechanism could involve binding of HO-1 to a transcription factor or a protein complex. Although HO-1 can bind to its isoenzyme HO-2 (45), no reports demonstrate binding of HO-1 to known transcription factors. However, HO-1 could bind to other proteins, serving as the non-DNA binding protein of a transcriptional factor complex as with the non-DNA-binding CBFbeta subunit of the core binding factor, which increases the affinity of the DNAbinding domain of CBFalpha for DNA while making no direct contacts to the DNA (50) . This remains to be determined.
With transcription factor signal arrays and EMSA assays, increased activation of AP-1 site was observed after transfection with active or inactive HO-1 protein. However, we did not observe increased Nrf2 binding activity on electrophoretic mobility assay. This is an important mechanism by which oxidative regulation occurs in many models (51, 52) . In the case of HO-1 gene regulation, the AP-1 subunit protein c-Jun does not appear to interact with Nrf2 but rather acts as a transactivator of the HO-1 promoter (27) . We observed increased phosphorylation of c-jun, a subunit of AP-1, suggesting that HO-1 protein delivery can lead to phosphorylation of the AP-1 complex proteins with resultant nuclear translocation and transcriptional activation. Whether phosphorylation of HO-1 is required for this signaling is not known. Whether HO-1 or other proteins complex with c-jun to modulate AP-1 binding is also not yet defined. Because HO-1 regulates both heme and iron levels in the cell, alterations in heme and/or iron and subsequent changes in cellular redox could have caused the change in AP-1 activation, as demonstrated by others (53) . In a previous report, transfection of mutant HO-1 protein into HO-1 deficient cells resulted in altered catalase gene expression (11) . This effect was attributed to accumulation of heme. In our model, cells with endogenous HO-1 protein were transfected with the mutant HO-1. This should not alter heme levels because the native HO-1 should maintain the heme equilibrium. Furthermore, delivery of both the native and mutant HO-1 protein had the same effect on AP-1 activation and the delivered HO-1 protein was relatively short-lived compared to the native form. Therefore, any effect on heme or iron levels would likely revert to normal within a few hours. In addition, if the changes in transcription factor activation were due to changes in heme and/or iron, we would have anticipated an increase in AP-1 and NF-kB activation rather than an increase in AP-1 and a decrease in NF-kB activation as shown because heme or iron positively regulate NF-kB activation as they do AP-1 (53).
Both enzymatically active and inactive HO-1 protein activated the transcription factors Brn-3, core binding factor (CBF) and AP-2. The class IV POU domain transcription factor Brn-3 family members alter differentiation, migration or survival of specific central neuronal populations (54) . The CBFs are required at various stages of hematopoiesis and the CBF transcription factor complex is essential for cell proliferation and viability and for initiating hematopoiesis in the embryo (55) . The transcription factor AP-2 plays an important role in embryonic development by influencing cell differentiation, proliferation and survival. It is also implicated in carcinogenesis and abnormal cell proliferation (56) .
Other transcription factors such as the CCAT displacement protein (CDP) and STAT3 were highly expressed with delivery of the active but not with the mutant inactive HO-1 protein. The differential activation of HO-1 protein delivery on CDP and Stat3 depending on HO activity suggests that one of the HO byproducts might modulate that expression of these proteins. In fact CO can modulate STAT3 activation and this is responsible for the anti-apoptotic effect of CO in endothelial cells (57) . No evidence exists regarding the effect of HO byproducts on CDP activation so far.
Overall, increased activation of transcription factors involved in cell proliferation such as Brn-3, CBF and AP-2 was observed after intracytoplasmic delivery would suggest that increased activation of these factors by HO-1 protein or its byproducts would likely increase cellular proliferation. Several reports suggest an anti-proliferative effect of the HO byproduct CO (58) (59) (60) . The role of HO-1 protein devoid of activity on cell proliferation needs to be systematically addressed. Nuclear localization of suggests that HO-1 protein may serve in a signaling capacity, perhaps to regulate cellular proliferation and upregulate antioxidant defenses.
The regulation of HO-1 gene expression by oxidative stress has been well characterized. The proximal enhancer region as well as two 5' distal enhancer regions, DE1 and DE2, mediates transcriptional activation of the HO-1 gene in response to various stimuli. Each enhancer region contains multiple copies of the cis-acting stress responsive element (StRE), similar to the Maf response element and binding sites of AP-1 class of transcription factors. Key regulators through DE1 and DE2 include the Nrf2 transcription factor which can heterodimerize to Maf and activate HO-1 gene transcription and Bach-1, a heme-regulated and hypoxia-inducible basic leucine zipper protein to represses HO-1 gene expression by binding to the multiple Maf recognition elements (MAREs) on the HO-1 gene (61) . Therefore the HO-1 promoter is a useful model to understand the effect of HO-1 on oxidative response elements. We demonstrate activation of the HO-1 promoter by the HO-1 protein whether it is active or not. We also show that full activation requires the Cterminus but that C-terminal truncation still mediates this activation. This reinforces the notion that HO-1 protein modulates oxidant-mediated cellular responses, likely through modulation of oxidant responsive transcription factors. Lastly, despite reduced activity, the truncated nuclear form of HO-1 protein retained its cytoprotective role against H 2 O 2 -mediated injury, further suggesting that the HO-1 protein itself is important to cellular cytoprotection. A previous report showed that transfection with an inactive mutant HO-1 increased catalase gene expression and glutathione content (11) . We also demonstrate here that transfection with HO-1 cDNA or delivery of HO-1 protein results in activation of various transcription factors whether the enzyme is active or not. This suggests that the HO-1 protein itself may play a role in cellular signaling. In contrast, no protection was provided against hemin-mediated injury. This is logical because HO activity is vital to the degradation of the prooxidant heme to antioxidant bile pigments. It will be important to understand what downstream effects result from HO-1 nuclear entry and how these precisely mediate cellular cytoprotection.
In summary, we have demonstrated that hypoxia and two other inducers of HO-1, heme and heme-hemopexin result in nuclear localization of HO-1 and that this process results from protease-mediated, C-terminal truncation of HO-1 protein linked to CRM1 mediated nucleocytoplasmic shuttling. Nuclear localization also reduces HO activity. Additionally, HO-1 protein altered binding of transcription factors involved in oxidative stress and allowed for protection against H 2 O 2 . We speculate that nuclear localization of HO-1 is an important signaling pathway to provide cytoprotection in the presence of oxidative stress. A). Immunocytostaining using antibody specific to the N-terminus of HO-1 (SPA 896; green signal) is shown. B) Representative co-localization (yellow) of HO-1 (green) with PI (red) using confocal microscopy through stacked Z series. Antibodies specific to the N-terminus (SPA 896) and C-terminus (M19) of the HO-1 were used to demonstrate the differential nuclear localization. C) Nuclear and cytoplasmic fractions were isolated from the Hepa cells incubated with hemin. These were subjected to Western analysis using antibodies against the N-and C-terminus of HO-1. The small arrow indicates the native HO-1 protein migrating at 32 kDa, the large arrow indicates the faster migrating (28 kDa) immunoreactive HO-1 signal. HEK293 cells were stably transfected with FLAGHO-1 cDNA. After exposure to 3% oxygen for 24 h intact nuclei were isolated and the protein was extracted. Purification and enrichment of the FLAGHO-1 were achieved with a FLAG affinity column. An aliquot of the eluent was denatured and loaded onto a 4-12% gradient acrylamide gel followed by electrophoresis. Colloidal blue staining of the gel revealed a predominant band between 30 to 45 kDa (arrow). The sample was used for determination of molecular mass and peptide sequencing as described in the Results section. Table 2 
